Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


25.09.2017

1 Arch Pediatr
2 J Gen Virol
10 J Infect Dis
2 J Virol
1 Lancet Glob Health
1 Lancet Oncol
1 Pediatr Infect Dis J
1 Pediatrics
1 PLoS Med
10 PLoS One
19 Vaccine
1 Virology
1 Wkly Epidemiol Rec


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Arch Pediatr

  1. BASTIEN AS, Serge Ganga-Zandzou P
    [Vaccination study of children in the North department, France].
    Arch Pediatr. 2017 Sep 11. pii: S0929-693X(17)30300.
    PubMed     Text format    


    J Gen Virol

  2. CARPENTIER DCJ, Hollinshead MS, Ewles HA, Lee SA, et al
    Tagging of the vaccinia virus protein F13 with mCherry causes aberrant virion morphogenesis.
    J Gen Virol. 2017 Sep 20. doi: 10.1099/jgv.0.000917.
    PubMed     Text format     Abstract available

  3. KANDEIL A, Kayed A, Moatasim Y, Webby RJ, et al
    Genetic characterization of highly pathogenic avian influenza A H5N8 viruses isolated from wild birds in Egypt.
    J Gen Virol. 2017 Jul 18. doi: 10.1099/jgv.0.000847.
    PubMed     Text format     Abstract available


    J Infect Dis

  4. MCELHANEY JE, McNeil SA
    Test-Negative Design: The Importance of Laboratory-Confirmed Illness in Estimating the Effectiveness of Influenza Vaccine in Older Adults.
    J Infect Dis. 2017;216:399-401.
    PubMed     Text format    

  5. OLIVER SE, Unger ER, Lewis R, McDaniel D, et al
    Prevalence of Human Papillomavirus Among Females After Vaccine Introduction-National Health and Nutrition Examination Survey, United States, 2003-2014.
    J Infect Dis. 2017;216:594-603.
    PubMed     Text format     Abstract available

  6. LIBRATY DH
    Effect of an Early Dose of Measles Vaccine on Morbidity Between 18 Weeks and 9 Months of Age: A Randomized, Controlled Trial in Guinea-Bissau.
    J Infect Dis. 2017;216:502-503.
    PubMed     Text format    

  7. VAN BEEK J, Veenhoven RH, Bruin JP, van Boxtel RAJ, et al
    Influenza-like Illness Incidence Is Not Reduced by Influenza Vaccination in a Cohort of Older Adults, Despite Effectively Reducing Laboratory-Confirmed Influenza Virus Infections.
    J Infect Dis. 2017;216:415-424.
    PubMed     Text format     Abstract available

  8. ANDREW MK, Shinde V, Ye L, Hatchette T, et al
    The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People.
    J Infect Dis. 2017;216:405-414.
    PubMed     Text format     Abstract available

  9. NEUZIL KM, Chen WH
    Influenza Vaccines for Older Persons: Progress and Pitfalls.
    J Infect Dis. 2017;216:397-398.
    PubMed     Text format    

  10. TAI CS, Wu JF, Chen HL, Ni YH, et al
    The Impact of Hepatitis B Vaccine Failure on Long-term Natural Course of Chronic Hepatitis B Virus Infection in Hepatitis B e Antigen-Seropositive Children.
    J Infect Dis. 2017;216:662-669.
    PubMed     Text format     Abstract available

  11. PODDIGHE D
    2-Dose Schedule of AS04-Adjuvanted Human Papillomavirus Types 16/18 Vaccine.
    J Infect Dis. 2017;216:782-783.
    PubMed     Text format    

  12. JONES EN, Amoah S, Cao W, Sambhara S, et al
    An Adjuvanted A(H5N1) Subvirion Vaccine Elicits Virus-Specific Antibody Response and Improves Protection Against Lethal Influenza Viral Challenge in Mouse Model of Protein Energy Malnutrition.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available

  13. LEVINE MZ, Holiday C, Liu F, Jefferson S, et al
    Cross-Reactive Antibody Responses to Novel H5Nx Influenza Viruses Following Homologous and Heterologous Prime-Boost Vaccination with a Prepandemic Stockpiled A(H5N1) Vaccine in Humans.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


    J Virol

  14. ANDERSEN TK, Zhou F, Cox R, Bogen B, et al
    A DNA vaccine that targets hemagglutinin to antigen presenting cells protects mice against H7 influenza.
    J Virol. 2017 Sep 20. pii: JVI.01340-17. doi: 10.1128/JVI.01340.
    PubMed     Text format     Abstract available

  15. MOONEY AJ, Gabbard JD, Li Z, Dlugolenski DA, et al
    Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
    J Virol. 2017 Sep 20. pii: JVI.01579-17. doi: 10.1128/JVI.01579.
    PubMed     Text format     Abstract available


    Lancet Glob Health

  16. ETHEART MD, Kligerman M, Augustin PD, Blanton JD, et al
    Effect of counselling on health-care-seeking behaviours and rabies vaccination adherence after dog bites in Haiti, 2014-15: a retrospective follow-up survey.
    Lancet Glob Health. 2017;5:e1017-e1025.
    PubMed     Text format     Abstract available


    Lancet Oncol

  17. CUZICK J
    Preventive therapy for cancer.
    Lancet Oncol. 2017;18:e472-e482.
    PubMed     Text format     Abstract available


    Pediatr Infect Dis J

  18. BAXTER RP, Lewis N, Fireman B, Hansen J, et al
    Live Attenuated Influenza Vaccination Prior To Age 3 Years and Subsequent Development of Asthma: A 14-Year Follow-Up Study.
    Pediatr Infect Dis J. 2017 Sep 12. doi: 10.1097/INF.0000000000001783.
    PubMed     Text format     Abstract available


    Pediatrics

  19. KINLAW AC, Sturmer T, Lund JL, Pedersen L, et al
    Trends in Antibiotic Use by Birth Season and Birth Year.
    Pediatrics. 2017 Aug 14. pii: e20170441. doi: 10.1542/peds.2017-0441.
    PubMed     Text format     Abstract available


    PLoS Med

  20. CANFELL K, Caruana M, Gebski V, Darlington-Brown J, et al
    Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    PLoS Med. 2017;14:e1002388.
    PubMed     Text format     Abstract available


    PLoS One

  21. LY HJ, Lokugamage N, Nishiyama S, Ikegami T, et al
    Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.
    PLoS One. 2017;12:e0185194.
    PubMed     Text format     Abstract available

  22. FRAIBERK M, Hajkova M, Krulova M, Kojzarova M, et al
    Exploitation of stable nanostructures based on the mouse polyomavirus for development of a recombinant vaccine against porcine circovirus 2.
    PLoS One. 2017;12:e0184870.
    PubMed     Text format     Abstract available

  23. LUEDERS I, Young D, Maree L, van der Horst G, et al
    Effects of GnRH vaccination in wild and captive African Elephant bulls (Loxodonta africana) on reproductive organs and semen quality.
    PLoS One. 2017;12:e0178270.
    PubMed     Text format     Abstract available

  24. KAR R, Nangpal P, Mathur S, Singh S, et al
    bioA mutant of Mycobacterium tuberculosis shows severe growth defect and imparts protection against tuberculosis in guinea pigs.
    PLoS One. 2017;12:e0179513.
    PubMed     Text format     Abstract available

  25. OSTENSSON E, Silfverschiold M, Greiff L, Asciutto C, et al
    The economic burden of human papillomavirus-related precancers and cancers in Sweden.
    PLoS One. 2017;12:e0179520.
    PubMed     Text format     Abstract available

  26. SARTORI AL, Minamisava R, Bierrenbach AL, Toscano CM, et al
    Reduction in all-cause otitis media-related outpatient visits in children after PCV10 introduction in Brazil.
    PLoS One. 2017;12:e0179222.
    PubMed     Text format     Abstract available

  27. PIPKINS HR, Bradshaw JL, Keller LE, Swiatlo E, et al
    Polyamine transporter potABCD is required for virulence of encapsulated but not nonencapsulated Streptococcus pneumoniae.
    PLoS One. 2017;12:e0179159.
    PubMed     Text format     Abstract available

  28. BYBERG S, Ostergaard MD, Rodrigues A, Martins C, et al
    Analysis of risk factors for infant mortality in the 1992-3 and 2002-3 birth cohorts in rural Guinea-Bissau.
    PLoS One. 2017;12:e0177984.
    PubMed     Text format     Abstract available

  29. WANG G, Yin R, Zhou P, Ding Z, et al
    Combination of the immunization with the sequence close to the consensus sequence and two DNA prime plus one VLP boost generate H5 hemagglutinin specific broad neutralizing antibodies.
    PLoS One. 2017;12:e0176854.
    PubMed     Text format     Abstract available

  30. EVANGELISTA KV, Lourdault K, Matsunaga J, Haake DA, et al
    Immunoprotective properties of recombinant LigA and LigB in a hamster model of acute leptospirosis.
    PLoS One. 2017;12:e0180004.
    PubMed     Text format     Abstract available


    Vaccine

  31. EATON A, Lewis N, Fireman B, Hansen J, et al
    Birth outcomes following immunization of pregnant women with pandemic H1N1 influenza vaccine 2009-2010.
    Vaccine. 2017 Sep 13. pii: S0264-410X(17)31180.
    PubMed     Text format     Abstract available

  32. JOO H, Maskery B, Mitchell T, Leidner A, et al
    A comparative cost analysis of the Vaccination Program for US-bound Refugees.
    Vaccine. 2017 Sep 14. pii: S0264-410X(17)31240.
    PubMed     Text format     Abstract available

  33. SKORSTENGAARD M, Thamsborg LH, Lynge E
    Burden of HPV-caused cancers in Denmark and the potential effect of HPV-vaccination.
    Vaccine. 2017 Sep 15. pii: S0264-410X(17)31160.
    PubMed     Text format     Abstract available

  34. BOHM K, Filomena A, Schneiderhan-Marra N, Krause G, et al
    Validation of HAV biomarker 2A for differential diagnostic of hepatitis A infected and vaccinated individuals using multiplex serology.
    Vaccine. 2017 Sep 14. pii: S0264-410X(17)31189.
    PubMed     Text format     Abstract available

  35. MO L, Chen Q, Zhang X, Shi X, et al
    Depletion of regulatory T cells by anti-ICOS antibody enhances anti-tumor immunity of tumor cell vaccine in prostate cancer.
    Vaccine. 2017 Sep 15. pii: S0264-410X(17)31224.
    PubMed     Text format     Abstract available

  36. ZIMMERMANN P, Curtis N
    The influence of probiotics on vaccine responses - A systematic review.
    Vaccine. 2017 Sep 15. pii: S0264-410X(17)31167.
    PubMed     Text format     Abstract available

  37. MANDAL S, Campbell H, Ribeiro S, Gray S, et al
    Risk of invasive meningococcal disease in university students in England and optimal strategies for protection using MenACWY vaccine.
    Vaccine. 2017 Sep 16. pii: S0264-410X(17)31241.
    PubMed     Text format     Abstract available

  38. PRINCIPI N, Esposito S
    Influenza vaccine use to protect healthy children: A debated topic.
    Vaccine. 2017 Sep 16. pii: S0264-410X(17)31232.
    PubMed     Text format     Abstract available

  39. HOWITZ MF, Harboe ZB, Ingels H, Valentiner-Branth P, et al
    A nationwide study on the impact of pneumococcal conjugate vaccination on antibiotic use and ventilation tube insertion in Denmark 2000-2014.
    Vaccine. 2017 Sep 16. pii: S0264-410X(17)31213.
    PubMed     Text format     Abstract available

  40. TAN S, Zhang S, Wu B, Zhao Y, et al
    Hemagglutinin-specific CD4+ T-cell responses following 2009-pH1N1 inactivated split-vaccine inoculation in humans.
    Vaccine. 2017 Sep 13. pii: S0264-410X(17)31159.
    PubMed     Text format     Abstract available

  41. AL-HUMADI N
    Pre-clinical toxicology considerations for vaccine development.
    Vaccine. 2017 Sep 12. pii: S0264-410X(17)31237.
    PubMed     Text format     Abstract available

  42. LISTORTI V, Laconi A, Catelli E, Cecchinato M, et al
    Identification of IBV QX vaccine markers : Should vaccine acceptance by authorities require similar identifications for all live IBV vaccines?
    Vaccine. 2017 Sep 13. pii: S0264-410X(17)30798.
    PubMed     Text format     Abstract available

  43. ALICINO C, Paganino C, Orsi A, Astengo M, et al
    The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on hospitalization for pneumonia in children: A systematic review and meta-analysis.
    Vaccine. 2017 Sep 11. pii: S0264-410X(17)31207.
    PubMed     Text format     Abstract available

  44. SUI X, Yan L, Jiang YY
    The vaccines and antibodies associated with Als3p for treatment of Candida albicans infections.
    Vaccine. 2017 Sep 11. pii: S0264-410X(17)31182.
    PubMed     Text format     Abstract available

  45. KHODR ZG, Bukowinski AT, Gumbs GR, Conlin AMS, et al
    Tetanus, diphtheria, and acellular pertussis vaccination during pregnancy and reduced risk of infant acute respiratory infections.
    Vaccine. 2017 Sep 12. pii: S0264-410X(17)31129.
    PubMed     Text format     Abstract available

  46. CHAMBERS CD, Xu R, Mitchell AA
    Commentary on: "Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12".
    Vaccine. 2017;35:5323-5324.
    PubMed     Text format    

  47. FRANKE MF, Jerome JG, Matias WR, Ternier R, et al
    Comparison of two control groups for estimation of oral cholera vaccine effectiveness using a case-control study design.
    Vaccine. 2017 Sep 12. pii: S0264-410X(17)31242.
    PubMed     Text format     Abstract available

  48. BRYSON PD, Han X, Truong N, Wang P, et al
    Breast cancer vaccines delivered by dendritic cell-targeted lentivectors induce potent antitumor immune responses and protect mice from mammary tumor growth.
    Vaccine. 2017 Sep 12. pii: S0264-410X(17)31233.
    PubMed     Text format     Abstract available

  49. DONAHUE JG, Kieke BA, King JP, DeStefano F, et al
    Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12.
    Vaccine. 2017;35:5314-5322.
    PubMed     Text format     Abstract available


    Virology

  50. HUYNH TP, Jancovich JK, Tripuraneni L, Heck MC, et al
    Characterization of a PKR inhibitor from the pathogenic ranavirus, Ambystoma tigrinum virus, using a heterologous vaccinia virus system.
    Virology. 2017 Sep 14. pii: S0042-6822(17)30275.
    PubMed     Text format     Abstract available


    Wkly Epidemiol Rec


  51. Meeting of the International Task Force for Disease Eradication, June 2017.
    Wkly Epidemiol Rec. 2017;92:537-56.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: